Historic settlement for over 1,300 survivors of clergy and adult abuse within the Roman Catholic Archdiocese of Los Angeles, marking a pivotal moment for justice.
July 1, 2025
Recently released Department of Justice information confirms that whistleblower provisions in the False Claims Act (FCA) remain a powerful tool to reign in fraud, waste and abuse in government programs.
2024 False Claims Act Highlights:
What is the False Claims Act?
The False Claims Act’s qui tam provision empowers individuals, known as “relators,” to file lawsuits on behalf of the government against businesses that have defrauded it. Essentially, it allows whistleblowers with inside knowledge of fraudulent activity, like overbilling or submitting false claims for government contracts, to step forward. The relator in these cases is uniquely able to expose wrongdoing in “qui tam” lawsuits that might otherwise remain hidden, and in return, they can receive a portion of the government’s recovery. The arrangement incentivizes individuals to report fraud, providing a crucial mechanism for uncovering and prosecuting those who attempt to cheat taxpayers, and ultimately, protects the integrity of public funds.
Fraud within government-funded healthcare programs — including Medicare, Medicaid and TRICARE — remained the primary source of False Claims Act settlements and judgments, including:
How Do We Fight Fraud Against the Government?
Seek justice on behalf of taxpayers with the help of our experienced attorneys. Our Dallas, Texas, whistleblower team has battled corporate giants for 20 years, aggressively fighting to hold corporations, individuals, and other entities accountable for fraud committed against the government. If you believe you have a whistleblower case, we can help.
Our Results
Historic settlement for over 1,300 survivors of clergy and adult abuse within the Roman Catholic Archdiocese of Los Angeles, marking a pivotal moment for justice.
A Philadelphia jury awarded a record verdict against ExxonMobil for failing to warn about cancer risks due to benzene in its petroleum products.
Private equity firm and co-defendants agree to pay $25M in Medicaid fraud case alleging mental health services provided by unqualified providers.